Citigroup shares rise sharply supported by Covid-19 vaccine news

Pharma company Moderna announced that it has a prospective vaccine which is 94.5% effective in preventing the COVID-19. Citigroup (NYSE: C) shares have advanced from $42 to $50.9 in less than five days and the current price stands around $50. Fundamental analysis: Citigroup is a stable bank but the price could weaken again Citigroup is an American multinational investment bank and financial services corporation headquartered in New York City. This is the third-largest banking institution in the United States with over 200 million customer accounts. Citigroup shares have advanced this Monday above $50 and the technical picture implies that the